Ultra-Early Combination Antiplatelet Therapy with Cilostazol for the Prevention of Branch Atheromatous Disease: A Multicenter Prospective Study

Ultra-Early Combination Antiplatelet Therapy with Cilostazol for the Prevention of Branch Atheromatous Disease: A Multicenter Prospective Study

Background and Purpose: The optimal use of antiplatelet therapy for intracranial branch atheromatous disease (BAD) is not known. Methods: We conducted a prospective multicenter, single-group trial of 144 consecutive patients diagnosed with probable BAD. All patients were treated within 12 h of sympt...

Full description

Bibliographic Details
Main Authors: Teruo Kimura, Adam Tucker, Toshihide Sugimura, Toshitaka Seki, Shin Fukuda, Satoru Takeuchi, Shiro Miyata, Tsutomu Fujita, Akira Hashizume, Naoto Izumi, Kazutsune Kawasaki, Makoto Katsuno, Masaaki Hashimoto, Kazuhiro Sako
Format: Article
Language:English
Published: Karger Publishers 2016-10-01
Series:Cerebrovascular Diseases Extra
Subjects:
Branch atheromatous disease
Cilostazol
Dual antiplatelet therapy
Progressive stroke
Online Access:http://www.karger.com/Article/FullText/450835

Internet

http://www.karger.com/Article/FullText/450835

Similar Items